Offical Claris Bio Logo - no background  - Logo over words.png
Claris Bio Emerges From Stealth With a New Investor and Prepares for Next Development Stage With Late-Stage Data Expected in 1H24
January 04, 2024 08:00 ET | Claris Biotherapeutics, Inc.
Claris Bio emerges from stealth with $57 million in funding as it prepares for 1H2024 readout of late-stage study in neurotrophic keratopathy
Amniotic Membrane Market Size Report ($2.80 Billion by 2028) Lead by Cryopreserved Amniotic Membrane Segment – Exclusive Report by The Insight Partners
February 21, 2023 08:08 ET | The Insight Partners
New York, Feb. 21, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Amniotic Membrane Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis...